Showing 151-160 of 1477 results for "".
Ophthalmic Presentations of Pituitary Adenoma
https://modernod.com/mod-issues/2020-nov-dec/ophthalmic-presentations-of-pituitary-adenoma/39115/The ocular examination can aid diagnosis and help guide treatment.A Diabetic Retinopathy Risk Factor Checklist
https://modernod.com/topics/retina/a-diabetic-retinopathy-risk-factor-checklist/38337/In addition to HbA1C, remember to evaluate patients for these 11 other systemic complications.DREAM Interpretations Abound Following Surprising Dry Eye Study Findings
https://modernod.com/topics/ocular-surface/dream-interpretations-abound-following-surprising-dry-eye-study-findings/39173/Control and placebo groups in DREAM both achieved similar improvements in OSDI scores; study authors concluded that omega-3 supplements were no better than the refined olive oil placebo.A New Era in Visual Field Testing
https://modernod.com/mod-issues/2021-mar/a-new-era-in-visual-field-testing/39119/Diagnostic testing moves to display tablets, virtual reality headsets, and websites.Glaucoma and Ocular Surface Disease: Understanding Visual Quality Related to Dry Eye
https://modernod.com/topics/glaucoma/glaucoma-and-ocular-surface-disease-understanding-visual-quality-related-to-dry-eye/38118/The Low-Down on Lasers
https://modernod.com/topics/business/the-low-down-on-lasers/48747/Here’s where optometry currently stands with scope expansion—and where we’re headed.One to Watch: Chris Kruthoff, OD, FAAO
https://modernod.com/topics/human-interest/one-to-watch-chris-kruthoff-od-faao/38637/One to Watch: Larae Zimprich, OD, FAAO
https://modernod.com/mod-issues/2022-mar/one-to-watch-larae-zimprich-od-faao/38387/Next-Level Allergy Management
https://modernod.com/mod-issues/2021-mar/next-level-allergy-management/38204/In-office testing takes the guesswork out of diagnosis and treatment.Long-Term Visual Outcomes with MacuHealth
https://modernod.com/topics/technology/long-term-visual-outcomes-with-macuhealth/37932/I recommend all my patients supplement their diets with a triple carotenoid therapy consisting of lutein, zeaxanthin, and meso-zeaxanthin.